| 1 |
Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients |
|
| | Tsitsi G. Monera-Penduka,Charles C. Maponga,Gene D. Morse,Charles F. B. Nhachi | | | Journal of Pharmaceutical Policy and Practice. 2017; 10(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The revised Declaration of Helsinki: cosmetic or real change? |
|
| | Aisha Y Malik,Charles Foster | | | Journal of the Royal Society of Medicine. 2016; 109(5): 184 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Appropriateness of no-fault compensation for research-related injuries from an African perspective: an appeal for action by African countries: Table 1 |
|
| | Patrick Dongosolo Kamalo,Lucinda Manda-Taylor,Stuart Rennie | | | Journal of Medical Ethics. 2016; 42(8): 528 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Compensation for Clinical Trial-Related Injury and Death in India: Challenges and the Way Forward |
|
| | Yogendra Kumar Gupta,Arun Kumar Pradhan,Aman Goyal,Prafull Mohan | | | Drug Safety. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan: A Questionnaire Survey |
|
| | Chieko Kurihara,Hideo Kusuoka,Shunsuke Ono,Naoko Kakee,Kazuyuki Saito,Kenji Takehara,Kiyokazu Tsujide,Yuzo Nabeoka,Takuya Sakuhiro,Hiroshi Aoki,Noriko Morishita,Chieko Suzuki,Shigeo Kachi,Emiko Kondo,Yukiko Komori,Tetsu Isobe,Shigeru Kageyama,Hiroshi Watanabe,David Joseph Diemert | | | PLoS ONE. 2014; 9(1): e84998 | | | [Pubmed] [Google Scholar] [DOI] | |
|
